Industry Advice

Updates on the GLP-1 MDL

This blog provides an update on the multidistrict litigation (MDL) involving claims related to GLP-1 RA medicines, also known as the “Ozempic MDL.” This class of medications includes Ozempic, Saxenda,…
Industry Advice
Next Page »